Well that is good news. Looks like they weren’t scared to meet with the FDA after all as a self proclaimed PRO had mentioned. They found a means of financing that wouldn’t be with Aspire and its dilution. Remember most recent biotech partnerships don’t wait for signing until a milestone is achieved, they can pay when they occur with Contingent Value Rights (CVRs), and that can be for any achievement including BTD. So I’m thinking anytime folks.
(2)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links